Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-01

Clinical Trial Update: Impact Of Metformin In Rectal Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of Phase 2 and Phase 3 trials evaluating metformin in rectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Minia University | Conditions: Rectal Cancer Patients | Phase 2, Phase 3 | Status: COMPLETED